The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 multicenter study evaluating the safety and efficacy of MHC class II-restricted MAGE-A3/A6 T-cell receptor engineered T cells (KITE-718) in patients with advanced cancers.
 
Partow Kebriaei
No Relationships to Disclose
 
Christopher Austin Klebanoff
Stock and Other Ownership Interests - Bluebird Bio; Bristol-Myers Squibb; Celgene; CVS Health; DaVita; Gilead Sciences
Honoraria - Kite, a Gilead company
Consulting or Advisory Role - Bristol-Myers Squibb; Cell Design Labs; Obsidian Therapeutics; RXI Pharmaceuticals
Research Funding - Kite, a Gilead company (Inst); Lilly (Inst); Roche/Genentech (Inst)
 
Ben C. Creelan
Consulting or Advisory Role - Abbvie; Celgene
Speakers' Bureau - ARIAD; AstraZeneca; Bristol-Myers Squibb; Genentech
Research Funding - Boehringer Ingelheim; Lion Biotechnologies
 
David S. Hong
Stock and Other Ownership Interests - MolecularMatch; Oncorena
Honoraria - Adaptimmune; Baxter; Bayer; Merrimack
Consulting or Advisory Role - Baxter; Bayer; Guidepoint Global; Janssen
Research Funding - Abbvie; Adaptimmune; Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Eisai; Genentech; Genmab; Ignyta; Infinity Pharmaceuticals; Kite, a Gilead company; Kyowa Hakko Kirin; Lilly; Loxo; MedImmune; Merck; Mirati Therapeutics; miRNA Therapeutics; Molecular Templates; Novartis; Pfizer; Takeda
Travel, Accommodations, Expenses - Loxo; miRNA Therapeutics
Other Relationship - Oncorena
 
George R. Blumenschein
Consulting or Advisory Role - Abbvie; ARIAD; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech; Merck
Research Funding - Abbvie (Inst); Adaptimmune (Inst); AstraZeneca (Inst); Bayer Schering Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); GlaxoSmithKline (Inst); immatics (Inst); Kite, a Gilead company (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); Xcovery (Inst)
 
Alexandra Drakaki
Research Funding - Kite/Gilead (Inst)
 
Ashutosh Tewari
Consulting or Advisory Role - Siemens
Research Funding - Axogen Inc; Intuitive Surgical; NIH
Patents, Royalties, Other Intellectual Property - DNA Based Bicistronic Vectors with Inducible and Constitutive Promoters ID#160608; High Intensity Focus Ultrasound and CPG-Brachyury-siRNA for Treatment of Prostate Cancer ID#160403; Patent for a Catherterless Device and Approach; Uretheral Catheterless Radical Prostatectomy
 
Lisa Thomrongsith
Employment - Gilead Sciences; Johnson & Johnson (I)
Stock and Other Ownership Interests - Gilead Sciences; Johnson & Johnson (I); Myovant Sciences (I)
Travel, Accommodations, Expenses - Johnson & Johnson (I); Kite/Gilead
 
Yizhou Jiang
Employment - Kite/Gilead
Stock and Other Ownership Interests - Gilead Sciences
 
Rajul K. Jain
Employment - Kite/Gilead
Stock and Other Ownership Interests - Amgen; Gilead Sciences